Apr 20, 2009 | Rehab Management
For Reducing Mortality, Current and Emerging Therapies Have No...
For Reducing Mortality, Current and Emerging Therapies Have No Advantage Over Carvedilol in the Treatment of Coronary Heart Disease WALTHAM, Mass.
Flamel Technologies to Receive $4 Million Milestone Payment from GlaxoSmithKline
Flamel Technologies announced today that it has earned an additional $4 million milestone from GlaxoSmithKline pursuant to its MicropumpA license agreement for Coreg CRa .
Are my heart medicines giving me infections? Dear Dr. Eva, I'm on several new prescription medications since I had a heart attack a few months ago.
Beta blockers, also called beta-adrenergic blocking agents, treat a variety of conditions, such as high blood pressure, glaucoma and migraines.